ScienceTech.euabout 2 hours ago
Respiro Diagnostics secures £1M to advance lung diagnostics
2 min read
Respiro Diagnostics raised £1 million in pre-seed funding led by Zinc Venture Capital and SFC Capital. The UK startup develops a non-invasive breath-based liquid biopsy platform to detect lung cancer and other respiratory diseases. Funding will support clinical research and device development.
Level
Hype check
Tap to vote and see what everyone thinks.
